Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms

被引:0
|
作者
Irene Lambrinoudaki
Panagiota Chatzivasileiou
Stefanos Stergiotis
Eleni Armeni
Dimitrios Rizos
George Kaparos
Areti Augoulea
Andreas Alexandrou
Georgios Georgiopoulos
Aggeliki Laina
Kimon Stamatelopoulos
机构
[1] National and Kapodistrian University of Athens,2nd Department of Obstetrics and Gynecology, Aretaieio Hospital
[2] National and Kapodistrian University of Athens,Hormonal and Biochemical Laboratory, Aretaieio Hospital
[3] National and Kapodistrian University of Athens,Vascular Laboratory, Department of Clinical Therapeutics, Alexandra Hospital, Medical School
来源
Heart and Vessels | 2018年 / 33卷
关键词
Subclinical atherosclerosis; Vascular stiffness; NOS3 G894T polymorphism; CYBA C242T polymorphism; Premenopausal women;
D O I
暂无
中图分类号
学科分类号
摘要
Genetic variations of genes encoding the endothelial nitric oxide synthase (eNOS) and the NADH/NADPH oxidase system are related with atherosclerosis in the general population, but their significance in women is not sufficiently assessed. We investigated the potential association between the G894T polymorphism of the NOS3 gene and the C242T polymorphism of the CYBA gene with subclinical vascular disease. Seventy (70) healthy, normally ovulating, premenopausal women were recruited for this study. Venous blood samples were obtained for biochemical/hormonal assessment as well as for genotyping, using real-time PCR. Sonographically assessed indices of vascular structure and function included carotid and femoral intima-media thickness (IMT), flow-mediated dilation (FMD), carotid-femoral pulse-wave velocity (PWV), and augmentation index. The prevalence of wild type, heterozygote, and homozygote genotype was 44.3% (31/70), 54.3% (38/70), and 1.4% (1/70) for the G894T polymorphism and 38.6% (27/70), 31.4% (22/70), and 30.0% (21/70) for the C242T polymorphism, respectively. After multivariable adjustment, the hC242T polymorphism was a predictor of both internal carotid IMT (b-coefficient − 0.119, p = 0.011) and combined-IMT (b-coefficient − 0.061, p = 0.015). Systolic blood pressure, lipids, and hC242T determined values of FMD (b-coefficient − 1.604, p = 0.034). Concerning the NOS3 G894T polymorphism, carriers of the polymorphic variant had higher values of IMT and PWV compared to the wild-type subgroup (carotid bulb-IMT and PWV, heterozygotes/homozygotes vs wild type 0.7 ± 0.2 vs 0.6 ± 0.1 mm; 7.1 ± 0.8 vs 6.6 ± 0.7 m/s; p = 0.048 and p = 0.029, respectively). These differences, however, were rendered non-significant in the multivariable analysis. In healthy premenopausal women, the CYBA C242T polymorphism is an independent determinant of endothelial function and subclinical atherosclerosis of the carotid arteries. The NOS3 G894T polymorphic variant also correlated with atherosclerosis, an association probably mediated by the traditional risk factors for CVD. The relevance of these findings in the clinical setting remains to be elucidated.
引用
收藏
页码:1434 / 1444
页数:10
相关论文
共 50 条
  • [1] Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms
    Lambrinoudaki, Irene
    Chatzivasileiou, Panagiota
    Stergiotis, Stefanos
    Armeni, Eleni
    Rizos, Dimitrios
    Kaparos, George
    Augoulea, Areti
    Alexandrou, Andreas
    Georgiopoulos, Georgios
    Laina, Aggeliki
    Stamatelopoulos, Kimon
    [J]. HEART AND VESSELS, 2018, 33 (12) : 1434 - 1444
  • [2] Association of Aquaporin-3, Aquaporin-7, NOS3 and CYBA polymorphisms with hypertensive disorders in women
    da Silva, Ines Vieira
    Santos, Ana Carolina
    Matos, Andreia
    da Silva, Alda Pereira
    Soveral, Graca
    Rebelo, Irene
    Bicho, Manuel
    [J]. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2021, 24 : 44 - 49
  • [3] ASSOCIATION OF AGT, ACE, NOS3, TNF, MMP9, CYBA POLYMORPHISM WITH SUBCLINICAL ARTERIAL WALL CHANGES
    Akopyan, A. A.
    Kirillova, K., I
    Strazhesko, I. D.
    Samokhodskaya, L. M.
    Orlova, I. A.
    [J]. KARDIOLOGIYA, 2021, 61 (03) : 57 - 65
  • [4] ASSOCIATION OF ARTERIAL STIFFNESS WITH AGT, ACE, NOS3, TNF, MMP9, CYBA POLYMORPHISM IN HEALTHY ADULTS
    Akopyan, Anna
    Kirillova, Karina
    Turchina, Tatiana
    Samokhodskaya, Larisa
    Strazhesko, Irina
    Orlova, Iana
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 : E265 - E265
  • [5] THE ASSOCIATION OF VASCULAR STIFFNESS PARAMETERS AND SUBCLINICAL ATHEROSCLEROSIS WITH BONE MASS IN POSTMENOPAUSAL WOMEN
    Skripnikova, I.
    Alikhanova, N.
    Tkacheva, O.
    Abirova, E.
    Novikov, V.
    Murashko, L.
    Sharashkina, N.
    Isaykina, O.
    Vygodin, V.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S126 - S126
  • [6] Association between NOS3 polymorphisms and arterial stiffness in children with type 1 diabetes.
    Zineh, I.
    Beitelshees, A. L.
    Haller, M. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S15 - S15
  • [7] Association between NOS3 polymorphisms and osteonecrosis of the femoral head
    Zhao, Xiaodong
    Yang, Fuqiang
    Sun, Luwei
    Zhang, Ali
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 1423 - 1427
  • [8] NOS3 gene polymorphisms and exercise hemodynamics in postmenopausal women
    Hand, B. D.
    McCole, S. D.
    Brown, M. D.
    Park, J. J.
    Ferrell, R. E.
    Huberty, A.
    Douglass, L. W.
    Hagberg, J. M.
    [J]. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2006, 27 (12) : 951 - 958
  • [9] PREDICTORS OF SUBCLINICAL ATHEROSCLEROSIS IN PREMENOPAUSAL WOMEN
    Aydin, Mesut
    Alemdar, Recai
    Cil, Habib
    Besir, Fahri Halit
    Ozhan, Hakan
    Aydin, Yusuf
    Bulur, Serkan
    Yazgan, Omer
    Kaya, Ahmet
    Basar, Cengiz
    [J]. ACTA MEDICA MEDITERRANEA, 2014, 30 (04): : 941 - 945
  • [10] Combinations of NOS3 and CYBA alleles and essential hypertension risk in men
    Makarevich, P. I.
    Andreenko, E. Yu.
    Balatsky, A. V.
    Kolotvin, A. V.
    Popova, N. O.
    Yarovaya, E. B.
    Samokhodskaya, L. M.
    Tkachuk, V. A.
    [J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (03): : 4 - 9